Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07314359

Rapid Effects of a Biofield Patch on Antioxidant Status and Cellular Energy

The goal for this clinical proof-of-concept study is to compare an active biofield skin patch to a placebo patch on antioxidant function and mitochondrial function. A double-blind, placebo-controlled cross-over study design will be used.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

NIS Labs

Klamath Falls, Oregon, 97601, United States

Location status: Recruiting

Location contact

Gitte S Jensen, PhD

CONTACT

[email protected]

5418820112

About this study

The goal for this clinical proof-of-concept study is to document acute effects of a photobiomodulating non-transdermal patch compared to a placebo patch, in an acute randomized double-blind placebo-controlled cross-over design. An add-on open-label module involves wearing the active patch daily for a week before the final clinic visit.

Data on endogenous antioxidant protection will be collected. The testing will show whether wearing the patch leads to a change in antioxidant activity of superoxide dismutase and glutathione. Data on cellular energy production and mitochondrial resilience in white blood cells under oxidative and inflammatory stress ex vivo will be collected. This testing will show whether using the active patch leads to changes in mitochondrial biogenesis and mitochondrial energy production under normal versus ex vivo-stressed conditions. Data on serum cytokine levels in both serum and serum-derived extracellular vesicles will be collected. The testing will show whether wearing the patch contributes to rapid change in pro- and anti-inflammatory markers and restorative growth factors.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy adults;
  • Age 18 - 75 years (inclusive);
  • BMI between 18.0 and 34.9 (inclusive);
  • Veins easy to see in one or both arms (to allow for the multiple blood draws);
  • Willing to comply with study procedures, including:
  • Maintaining a consistent diet and lifestyle routine throughout the study,
  • Consistent habit of bland breakfasts on days of clinic visits,
  • Abstaining from exercising and nutritional supplements on the morning of a study visit,
  • Abstaining from use of coffee, tea, and soft drinks for at least one hour prior to a clinic visit;
  • Abstaining from music, candy, gum, computer/cell phone use (airplane mode is allowed), during clinic visits.

Exclusion criteria

  • Cancer during past 12 months;
  • Chemotherapy during past 12 months;
  • Currently taking prescription weight loss drugs (such as semaglutide);
  • Currently taking cholesterol-lowering medication (for example: statins);
  • Currently experiencing intense stressful events/life changes;
  • Currently in intensive athletic training (such as marathon runners);
  • Currently taking anxiolytic, hypnotic, or anti-depressant prescription medication;
  • Immunization during past 6 months;
  • An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying);
  • Unwilling to maintain a constant intake of supplements over the duration of the study;
  • Anxiety about having blood drawn;
  • Pregnant, nursing, or trying to become pregnant;
  • Known allergies related to adhesive materials.

Treatment and study plan

Active dermal patch

Other

Non-transdermal patch

Placebo dermal patch

Other

Non-transdermal patch

Primary outcomes

  1. Antioxidant protection

    Time frame: Baseline, 1 hour, and 2 hours after applying a patch.

    Data will be collected on intracellular levels of reduced glutathione and serum superoxide dismutase activity.

Secondary outcomes

  1. Mitochondrial volume per cell

    Time frame: Baseline, 1 hour, and 2 hours after applying a patch.

    Mitochondrial volume per cell, measured by flow cytometry where the mean fluorescence intensity (MFI) is quantified on lymphocytes, monocytes, and polymorphonuclear cells. White blood cells are purified and cultured ex vivo in unstressed versus inflamed culture conditions. The mitochondrial reporter dye MitoTracker is used to obtain relative measures of mitochondrial volume per cell.

  2. Mitochondrial membrane potential per cell

    Time frame: Baseline, 1 hour, and 2 hours after applying a patch

    Cellular energy production as a function of the mitochondrial membrane potential where the mean fluorescence intensity (MFI) is quantified on lymphocytes, monocytes, and polymorphonuclear cells. White blood cells are purified and cultured ex vivo in unstressed versus inflamed culture conditions. The mitochondrial reporter dye JC-1 is a fluorescent cationic dye used to obtain relative measures of mitochondrial membrane potential per cell.

Other outcomes

  1. Communication in the body via serum cytokines

    Time frame: Baseline, 1 hour, and 2 hours after applying a patch.

    Data on serum levels of 27 pro- and anti-inflammatory cytokines and regenerative growth factors will be collected.

  2. Communication in the body via cytokines in extracellular vesicles

    Time frame: Baseline, 1 hour, and 2 hours after applying a patch.

    Data on the levels of 27 pro- and anti-inflammatory cytokines and regenerative growth factors in serum extracellular vesicles will be collected.

Study contacts

Contact information is provided by the study sponsor or research team.

Alex Cruickshank

CONTACT

Giite S Jensen, PhD

CONTACT

[email protected]

5418820112

Sponsors and collaborators

Lead sponsor

Natural Immune Systems Inc

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 2, 2026
Registry last updated
Jan 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.